Shengxiang Ren

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Thoracic cancer

The Journal of experimental medicine

International journal of cancer

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Chuchu Shao, Xinxin Zhi, Shiqi Mao, Leilei Wu, Jia Yu, Shuo Yang, Wanying Wang, Keyi Jia, Libo Luo, Xinyu Liu, Tao Jiang, Caicun Zhou, Bin Chen, Lei Wang, Guanghui Gao, Jingyun Shi, Xiaoxia Chen, Fengying Wu, Shengxiang Ren
Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease. Thoracic cancer 15 (10) (2024)
Tao Jiang, Qiqi Jin, Jiahao Wang, Feng-Ying Wu, Jian Chen, Gongyan Chen, Yunchao Huang, Jianhua Chen, Ying Cheng, Qi-Ming Wang, Yue-Yin Pan, Jian-Ying Zhou, Jianhua Shi, Xingxiang Xu, LiZhu Lin, Wei Zhang, Yiping Zhang, Yun-Peng Liu, Yong Fang, Jifeng Feng, Zhehai Wang, Sheng Hu, Jian Fang, Yongqian Shu, Jiu-Wei Cui, Yi Hu, Wenxiu Yao, Xingya Li, Xiaoyan Lin, Rui Wang, Yongsheng Wang, Wei Shi, Gaohua Feng, Jun Ni, Beibei Mao, Dandan Ren, Huaibo Sun, Henghui Zhang, Luo-Nan Chen, Cai-Cun Zhou, Shengxiang Ren
HLA-I evolutionary divergence confers response to PD-1 blockade plus chemotherapy in untreated advanced non-small-cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Guanghui Gao, Longgang Cui, Fei Zhou, Tao Jiang, Wanying Wang, Shiqi Mao, Fengying Wu, Fangli Jiang, Bei Zhang, Ting Bei, Wenchuan Xie, Cheng Zhang, Hougang Zhang, Chan Gao, Xiaochen Zhao, Yuezong Bai, Caicun Zhou, Shengxiang Ren
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer. International journal of cancer 152 (1) (2022)
Shiqi Mao, Fei Zhou, Yiwei Liu, Shuo Yang, Bin Chen, Jian Xu, Fengying Wu, Xuefei Li, Chao Zhao, Wanying Wang, Qian Liu, Xiaofei Yu, Keyi Jia, Chuchu Shao, Caicun Zhou, Guanghui Gao, Shengxiang Ren
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC. Cancer immunology, immunotherapy : CII (2021)
Juan Zhou, Chao Zhao, Jing Zhao, Qi Wang, Xiangling Chu, Jiayu Li, Fei Zhou, Shengxiang Ren, Xuefei Li, Chunxia Su, Caicun Zhou
Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure. Thoracic cancer 10 (4) (2019)
Yingying Pan, Guanghui Gao, Xiaoxia Chen, Qinrui Tian, Fengying Wu, Qian Liu, Yan Wang, Tao Jiang, Yiwei Liu, Xuefei Li, Shuo Yang, Chuan Xu, Chunxia Su, Fei Zhou, Shengxiang Ren, Caicun Zhou
Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancer. Thoracic cancer 10 (4) (2019)
Yijun Jia, Xuefei Li, Tao Jiang, Sha Zhao, Chao Zhao, Limin Zhang, Xiaozhen Liu, Jinpeng Shi, Meng Qiao, Jiawei Luo, Sangtian Liu, Ruoshuang Han, Chunxia Su, Shengxiang Ren, Caicun Zhou
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapies. International journal of cancer 145 (5) (2019)
Xibin Zhuang, Chao Zhao, Jiayu Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Xuefei Li, Caicun Zhou
Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF. Cancer medicine 8 (6) (2019)
Xiaoyun Zhou, Jiawei Shou, Jin Sheng, Chunwei Xu, Shengxiang Ren, Xiuyu Cai, Qian Chu, Wenxian Wang, Qinhong Zhen, Yuefen Zhou, Wenfeng Li, Hong Pan, Hongsen Li, Tao Sun, Huanqing Cheng, Huina Wang, Feng Lou, Chuangzhou Rao, Shanbo Cao, Hongming Pan, Yong Fang
Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer. Cancer science 110 (10) (2019)
Tao Jiang, Qian Chu, Huijuan Wang, Fei Zhou, Guanghui Gao, Xiaoxia Chen, Xuefei Li, Chao Zhao, Qinghua Xu, Wei Li, Fengying Wu, Anwen Xiong, Jing Zhao, Yaping Xu, Chunxia Su, Shengxiang Ren, Caicun Zhou, Fred R Hirsch
EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases. International journal of cancer 144 (10) (2018)
Terry L Ng, Yiwei Liu, Anastasios Dimou, Tejas Patil, Dara L Aisner, Zhengwei Dong, Tao Jiang, Chunxia Su, Chunyan Wu, Shengxiang Ren, Caicun Zhou, D Ross Camidge
Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer. Cancer 125 (7) (2018)